- Home
- VSTD vs TENX Comparison
VSTD vs TENX Comparison
Compare VSTD & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTD
- TENX
- Stock Information
- Founded
- VSTD N/A
- TENX 1967
- Country
- VSTD United States
- TENX United States
- Employees
- VSTD N/A
- TENX N/A
- Industry
- VSTD Restaurants
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- VSTD Consumer Discretionary
- TENX Health Care
- Exchange
- VSTD Nasdaq
- TENX Nasdaq
- Market Cap
- VSTD 30.3M
- TENX 27.3M
- IPO Year
- VSTD 2022
- TENX N/A
- Fundamental
- Price
- VSTD N/A
- TENX $6.09
- Analyst Decision
- VSTD
- TENX Strong Buy
- Analyst Count
- VSTD 0
- TENX 4
- Target Price
- VSTD N/A
- TENX $16.67
- AVG Volume (30 Days)
- VSTD N/A
- TENX 34.8K
- Earning Date
- VSTD N/A
- TENX 11-12-2025
- Dividend Yield
- VSTD N/A
- TENX N/A
- EPS Growth
- VSTD N/A
- TENX N/A
- EPS
- VSTD N/A
- TENX N/A
- Revenue
- VSTD N/A
- TENX N/A
- Revenue This Year
- VSTD N/A
- TENX N/A
- Revenue Next Year
- VSTD N/A
- TENX N/A
- P/E Ratio
- VSTD N/A
- TENX N/A
- Revenue Growth
- VSTD N/A
- TENX N/A
- 52 Week Low
- VSTD N/A
- TENX $3.25
- 52 Week High
- VSTD N/A
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- VSTD N/A
- TENX 56.75
- Support Level
- VSTD N/A
- TENX $5.97
- Resistance Level
- VSTD N/A
- TENX $6.22
- Average True Range (ATR)
- VSTD 0.00
- TENX 0.12
- MACD
- VSTD 0.00
- TENX 0.02
- Stochastic Oscillator
- VSTD 0.00
- TENX 57.53
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.